Pembrolizumab-Induced Simultaneous and Refractory Systemic Capillary Leak and Cytokine Release Syndromes: A Case Report
Systemic Capillary Leak Syndrome (SCLS) and Cytokine Release Syndrome (CRS) have both been described as rare but severe adverse reactions induced by Programmed cell death protein 1 (PD-1) inhibitors such as pembrolizumab. We report the case of a 40-year-old woman undergoing treatment with pembrolizu...
Gardado en:
| Principais autores: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
MDPI AG
2025-08-01
|
| Series: | Current Oncology |
| Assuntos: | |
| Acceso en liña: | https://www.mdpi.com/1718-7729/32/8/469 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|